Souhaitez-vous accéder aux communiqués récents ?

Spur Therapeutics Presents New Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at 22nd Annual WORLDSymposium

SANGAMO THERAPEUTICS PRESENTS DETAILED DATA FROM REGISTRATIONAL STAAR STUDY IN FABRY DISEASE AT WORLDSYMPOSIUM 2026

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Gene Therapy, RNA-based Therapies), Service,...

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "North America, Europe & Asia-Pacific Gene Therapy Cell Culture Media Market Forecast to 2033" report has been added to ResearchAndMarkets.com's...

Siren Biotechnology Announces FDA Clearance of First IND, Advancing Company to Clinical Stage

Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15...

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Gene Therapy Market" has been added to ResearchAndMarkets.com's offering. The gene therapy market is forecasted to expand significantly, with a...

Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Partnership for Cardiac RNA Therapies

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Adeno Associated Virus Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Business Outlook" report has been added to ResearchAndMarkets.com's offering.The Twice-Monthly Publication Cell and Gene Therapy...